Retatrutide20mg

Research code: LY3437943
CAS number: CAS2381089-83-2
Molecular formula: C₂₂₁H₃₄₂N₄₆O₆₈

Double-strength 20mg vial of the investigational GIP / GLP-1 / glucagon receptor triple agonist for extended research protocols.

Strength

02 options

Quantity

$85.00

Per vial · 20mg

In stockShips in plain packaging

Checking today's dispatch window…

Cutoff 2pm PT

Arrives: Calculating…
Packaging: Tracked, discreet
Checkout: Secure, encrypted

We accept

Research use only:Not for human or veterinary use. Not a drug, food, cosmetic or dietary supplement. Must be handled by qualified professionals.

(01)Overview

Triple-agonist research peptide

Retatrutide (LY3437943) is a single-molecule agonist of the GIP, GLP-1, and glucagon receptors, studied for its combined effects on metabolic signalling, energy expenditure, and hepatic lipid handling.

The 20mg format is intended for laboratories running longer or higher-throughput study designs, reducing vial count and handling steps per protocol.

Retatrutide remains an investigational compound and is not approved for any therapeutic use. Each vial is lyophilized, sealed under sterile conditions, and traceable to a batch Certificate of Analysis.

Research areas

Metabolic & weight-regulation research

(02)Specifications

DSL-RETA-20

Research code: LY3437943
CAS number: 2381089-83-2
Molecular formula: C₂₂₁H₃₄₂N₄₆O₆₈
Molecular weight: ≈ 4731.3 g/mol
Content: 20mg per vial
Form: Lyophilized powder
Purity (HPLC): See batch COA

(03)Certificate of Analysis

Third-party · per batch

Each batch is analysed by an independent laboratory (HPLC for purity, mass spectrometry for identity) and the certificate is matched to the batch number printed on the vial.

Status Upload pending

The certificate for the current batch of Retatrutide 20mg hasn't been published yet. Request it and we'll send the full report.

(04)Storage & handling

Storage

Store lyophilized vials at −20 °C, protected from light and moisture. After reconstitution, refrigerate at 2–8 °C.

Handling

Handle in a controlled laboratory environment with appropriate PPE and aseptic technique. Minimise freeze–thaw cycles and exposure to light and moisture. Dispose of materials per your institution's procedures.

(05)Research use

Compliance

For laboratory research use only.

Retatrutide 20mg is supplied strictly for in-vitro research and laboratory identification by qualified professionals. It is not a drug, food, dietary supplement or cosmetic and is not intended for human or veterinary use of any kind.

This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure or prevent any disease. Darkside Labs does not provide usage or administration guidance. The purchaser assumes full responsibility for safe handling and lawful use.

Also in the catalog

03 compounds